Latest filing published 09 Jun 2025 for Tango Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +115.2%Entry US$3.85 · Close at T+365 US$8.28
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mace Rothenberg: trading record in brief
This profile gathers the share dealings of Mace Rothenberg in Tango Therapeutics, Inc. In total, 5 filings cover trades dated from 6 June 2023 to 5 June 2025.
Purchases make up the whole of the open-market record (2 purchases, €70k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants.
The record was last updated on 9 June 2025 with a share grant in Tango Therapeutics, Inc. The clock since the last published purchase (18 November 2024) now reads 720 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mace Rothenberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,250 shares0Common StockSEC:0000950170-25-083907:0
- 10,000 shares@ US$3.62100.0% of flowCommon StockSEC:0000950170-24-128163:0Canonical exit: 12 Feb 2025 (T+90)
- 6,250 shares0Common StockSEC:0000950170-24-070884:0
- 5,000 shares0Common StockSEC:0000899243-23-015020:0
4 of 4 declarations